Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

Joel M. Reid, Chad A. Walden, Rui Qin, Katie L. Allen Ziegler, John L. Haslam, Roger A. Rajewski, Roger Warndahl, Cindy L. Fitting, Daniel Boring, Eva Szabo, James Crowell, Marjorie Perloff, Ling Jong, Brent A. Bauer, Sumithra J. Mandrekar, Matthew M. Ames, Paul J. Limburg

Research output: Contribution to journalArticle

26 Scopus citations

Fingerprint Dive into the research topics of 'Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668'. Together they form a unique fingerprint.

Medicine & Life Sciences